These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6488400)

  • 1. Studies on antidiabetic agents. IV. Synthesis and activity of the metabolites of 5-[4-(1-methylcyclohexylmethoxy)benzyl]-2,4-thiazolidinedione (ciglitazone).
    Sohda T; Meguro K; Kawamatsu Y
    Chem Pharm Bull (Tokyo); 1984 Jun; 32(6):2267-78. PubMed ID: 6488400
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on antidiabetic agents. VI. Asymmetric transformation of (+/-)-5-[4-(1-methylcyclohexylmethoxy)benzyl]-2,4- thiazolidinedione(ciglitazone) with optically active 1-phenylethylamines.
    Sohda T; Mizuno K; Kawamatsu Y
    Chem Pharm Bull (Tokyo); 1984 Nov; 32(11):4460-5. PubMed ID: 6532548
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on antidiabetic agents. Synthesis and hypoglycemic activity of 5-[4-(pyridylalkoxy)benzyl]-2,4-thiazolidinediones.
    Sohda T; Momose Y; Meguro K; Kawamatsu Y; Sugiyama Y; Ikeda H
    Arzneimittelforschung; 1990 Jan; 40(1):37-42. PubMed ID: 2339998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents.
    Sohda T; Mizuno K; Momose Y; Ikeda H; Fujita T; Meguro K
    J Med Chem; 1992 Jul; 35(14):2617-26. PubMed ID: 1635060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel euglycemic and hypolipidemic agents: Part-2. Antioxidant moiety as structural motif.
    Reddy KA; Lohray BB; Bhushan V; Reddy AS; Kishore PH; Rao VV; Saibaba V; Bajji AC; Rajesh BM; Reddy KV; Chakrabarti R; Rajagopalan R
    Bioorg Med Chem Lett; 1998 May; 8(9):999-1002. PubMed ID: 9871696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on antidiabetic agents. II. Synthesis of 5-[4-(1-methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione (ADD-3878) and its derivatives.
    Sohda T; Mizuno K; Imamiya E; Sugiyama Y; Fujita T; Kawamatsu Y
    Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3580-600. PubMed ID: 7160012
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on antidiabetic agents. XII. Synthesis and activity of the metabolites of (+/-)-5(-)[p(-)[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]-2,4- thiazolidinedione (pioglitazone).
    Sohda T; Ikeda H; Meguro K
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2168-72. PubMed ID: 8582019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent.
    Fujita T; Sugiyama Y; Taketomi S; Sohda T; Kawamatsu Y; Iwatsuka H; Suzuoki Z
    Diabetes; 1983 Sep; 32(9):804-10. PubMed ID: 6354788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antidiabetic activity of novel 2,4-thiazolidinedione derivatives containing a thiazole ring.
    Bozdağ-Dündar O; Ceylan-Unlüsoy M; Verspohl EJ; Ertan R
    Arzneimittelforschung; 2006; 56(9):621-5. PubMed ID: 17063636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
    Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR
    Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel euglycemic and hypolipidemic agents. 1.
    Lohray BB; Bhushan V; Rao BP; Madhavan GR; Murali N; Rao KN; Reddy AK; Rajesh BM; Reddy PG; Chakrabarti R; Vikramadithyan RK; Rajagopalan R; Mamidi RN; Jajoo HK; Subramaniam S
    J Med Chem; 1998 May; 41(10):1619-30. PubMed ID: 9572887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel phthalazinone and benzoxazinone containing thiazolidinediones as antidiabetic and hypolipidemic agents.
    Madhavan GR; Chakrabarti R; Kumar SK; Misra P; Mamidi RN; Balraju V; Kasiram K; Babu RK; Suresh J; Lohray BB; Lohrayb VB; Iqbal J; Rajagopalan R
    Eur J Med Chem; 2001; 36(7-8):627-37. PubMed ID: 11600232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel benzoxazole 2,4-thiazolidinediones as potent hypoglycemic agents. Synthesis and structure-activity relationships.
    Arakawa K; Inamasu M; Matsumoto M; Okumura K; Yasuda K; Akatsuka H; Kawanami S; Watanabe A; Homma K; Saiga Y; Ozeki M; Iijima I
    Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):1984-93. PubMed ID: 9433768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on antidiabetic agents. I. Synthesis of 5-[4-(2-methyl-2-phenylpropoxy)-benzyl]thiazolidine-2,4-dione (AL-321) and related compounds.
    Sohda T; Mizuno K; Tawada H; Sugiyama Y; Fujita T; Kawamatsu Y
    Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3563-73. PubMed ID: 7160011
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and antihyperglycemic activity of novel 5-(naphthalenylsulfonyl)-2,4-thiazolidinediones.
    Zask A; Jirkovsky I; Nowicki JW; McCaleb ML
    J Med Chem; 1990 May; 33(5):1418-23. PubMed ID: 2329563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone.
    Tanis SP; Parker TT; Colca JR; Fisher RM; Kletzein RF
    J Med Chem; 1996 Dec; 39(26):5053-63. PubMed ID: 8978836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on antidiabetic agents. X. Synthesis and biological activities of pioglitazone and related compounds.
    Momose Y; Meguro K; Ikeda H; Hatanaka C; Oi S; Sohda T
    Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1440-5. PubMed ID: 1934164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and hypoglycemic activity of some substituted flavonyl thiazolidinedione derivatives--fifth communication: flavonyl benzyl substituted 2,4-thiazolidinediones.
    Tunçbilek M; Bozdağ-Dündar O; Ayhan-Kilcigil G; Ceylan M; Waheed A; Verspohl EJ; Ertan R
    Farmaco; 2003 Jan; 58(1):79-83. PubMed ID: 12595040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel tricyclic-alpha-alkyloxyphenylpropionic acids: dual PPARalpha/gamma agonists with hypolipidemic and antidiabetic activity.
    Sauerberg P; Pettersson I; Jeppesen L; Bury PS; Mogensen JP; Wassermann K; Brand CL; Sturis J; Wöldike HF; Fleckner J; Andersen AS; Mortensen SB; Svensson LA; Rasmussen HB; Lehmann SV; Polivka Z; Sindelar K; Panajotova V; Ynddal L; Wulff EM
    J Med Chem; 2002 Feb; 45(4):789-804. PubMed ID: 11831892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antidiabetic and hypolipidemic agents. 3. Benzofuran-containing thiazolidinediones.
    Reddy KA; Lohray BB; Bhushan V; Bajji AC; Reddy KV; Reddy PR; Krishna TH; Rao IN; Jajoo HK; Rao NV; Chakrabarti R; Dileepkumar T; Rajagopalan R
    J Med Chem; 1999 Jun; 42(11):1927-40. PubMed ID: 10354401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.